Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 12,841 $ 33,469
Restricted cash and cash equivalents—current 4,841 4,978
Accounts receivable, net 282 2,188
Inventory 1,361 1,535
Prepaid expenses and other current assets 14,664 22,615
Total current assets 33,989 64,785
Restricted cash and cash equivalents—non current 614 598
Vehicle deposits 45,319 48,783
Vehicles, net 94,113 100,088
Goodwill 29,437 0
Other assets 10,285 11,402
Total assets 213,757 225,656
Current liabilities:    
Accounts payable 20,403 20,235
Accrued expenses 28,310 33,413
Deferred revenue 44,732 47,820
Notes payable—current 19,500 22,200
Other current liabilities 11,036 10,950
Total current liabilities 123,981 134,618
Notes payable—non current (including $61.8 million at March 31, 2023 and $30.1 million at December 31, 2022 of Convertible Senior Secured Notes measured at fair value) 87,691 56,205
Derivative liabilities 3,269 1,892
Other liabilities 6,386 7,831
Total liabilities 221,327 200,546
Commitments and contingencies (Note 12)
Stockholders’ Deficit    
Class A common stock, $0.0001 par value, 1,000,000,000 shares authorized, and 284,581,178 and 262,695,741 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively, and Class X common stock, $0.0001 par value, 50,000,000 shares authorized, 34,534,930 shares issued and outstanding as of March 31, 2023 and December 31, 2022 32 30
Additional paid-in capital 1,583,751 1,572,576
Accumulated other comprehensive loss (7,160) (7,621)
Accumulated deficit (1,584,193) (1,539,875)
Total stockholders’ (deficit) equity (7,570) 25,110
Total liabilities and stockholders’ equity $ 213,757 $ 225,656